Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jul 5;3(1):20210008. doi: 10.1259/bjro.20210008

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 The Authors. Published by the British Institute of Radiology

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

PMC Copyright notice

Figure 5. — Example of a 36-year-old female patient with recurrent CCA in the left liver lobe after right hemihepatectomy and systemic chemotherapy (gemcitabine/cisplatin), not detected on CT and MRI. Recurrence was suspected clinically by elevated tumor markers (CA 19.9). Before PET/CT, clinicians intended further imaging and biopsy to prove suspected recurrence, and revised their “non-treatment” strategy into a “palliative treatment” goal (with change of chemotherapy regimen) after PET/CT (major change).